Medicine & Life Sciences
Acute Myeloid Leukemia
19%
Allogeneic Cells
72%
B-Cell Chronic Lymphocytic Leukemia
8%
B-Cell Lymphoma
12%
Bone Marrow
29%
Busulfan
17%
Cell Transplantation
100%
Cell- and Tissue-Based Therapy
15%
Chimeric Antigen Receptors
14%
Confidence Intervals
12%
Cyclophosphamide
12%
Cytokine Release Syndrome
9%
Drug Therapy
12%
Fetal Blood
10%
fludarabine
15%
Graft vs Host Disease
39%
Granulocyte Colony-Stimulating Factor
16%
Hematologic Neoplasms
19%
Hematopoietic Stem Cell Mobilization
12%
Hematopoietic Stem Cell Transplantation
35%
Hematopoietic Stem Cells
20%
Homologous Transplantation
19%
Imatinib Mesylate
14%
Leukemia
11%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13%
Lymphoma
10%
Lymphoma, Large B-Cell, Diffuse
17%
Melphalan
15%
Mortality
20%
Multiple Myeloma
20%
Myelodysplastic Syndromes
13%
Non-Hodgkin's Lymphoma
18%
Peripheral Blood Stem Cells
13%
Placebos
8%
plerixafor octahydrochloride
18%
Progression-Free Survival
14%
Recurrence
23%
Siblings
12%
Stem Cell Transplantation
29%
Stem Cells
15%
Survival
27%
T-Lymphocytes
18%
Therapeutics
14%
Thiotepa
12%
tisagenlecleucel
31%
Tissue Donors
21%
Transplantation
28%
Transplants
58%
Unrelated Donors
26%
Whole-Body Irradiation
16%